48th AGM of the Company to be held on Friday, 05th September, 2025 at 4:00 PM (IST)
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eiko Lifesciences has issued the notice for its 48th AGM on Friday, 5th September 2025 at 4:00 PM, to be held via video conferencing. Ordinary business includes adoption of audited standalone and consolidated financial statements for FY ending 31 March 2025 and the re-appointment of Mr. Laxmikant Kabra as a Director liable to retire by rotation. Special business includes appointing M/s. Shravan Gupta & Associates as Secretarial Auditors for 5 years (FY 2025-26 to FY 2029-30) at a proposed fee of Rs. 75,000, approving material related party transactions worth up to Rs. 20 crore with promoter-related entities and subsidiaries, and increasing the authorised share capital from Rs. 14 crore (1.4 crore shares of Rs. 10) to Rs. 20 crore (2 crore shares of Rs. 10). Additional items include appointing Mr. Sumukh Prabhakar Vartak as Whole Time Director for 5 years at Rs. 6 lakh per annum, and re-appointing Independent Directors Ms. Kajal Kothari (term from 8 Sep 2025) and Mr. Rajkumar Baheti (term from 9 Feb 2026) for second 5-year terms. Remote e-voting opens 2 September 2025 and closes 4 September 2025, with the cut-off date set at 29 August 2025.
Shareholders will vote on a significant capital structure change that could enable future fundraising, along with several governance appointments and related party transactions involving promoter entities. Promoter group entities cannot vote on the related party resolution. Investors should review the explanatory statement and cast votes before 4 September 2025.